No black box warning on record for Vocabria

As of the latest FDA labeling reviewed, Vocabria (CABOTEGRAVIR SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Vocabria medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • HIV-1 PrEP: Comprehensive management to reduce the risk of HIV-1 acquisition. ( 5.1 ) • Serious or severe hypersensitivity reactions have been reported with cabotegravir and include Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Discontinue VOCABRIA immediately if signs or symptoms of hypersensitivity reactions develop. ( 5.2 ) • Hepatotoxicity has be

No black box warning on record for Vocabria

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • HIV-1 PrEP: Comprehensive management to reduce the risk of HIV-1 acquisition. ( 5.1 ) • Serious or severe hypersensitivity reactions have been reported with cabotegravir and include Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Discontinue VOCABRIA immediately if signs or symptoms of hypersensitivity reactions develop. ( 5.2 ) • Hepatotoxicity has be

Vocabria Black Box Warning

No black box warning on record for Vocabria

Other warnings & precautions

Vocabria Black Box Warning

No black box warning on record for Vocabria

Other warnings & precautions